Use of Postexposure Prophylaxis after Occupational Exposure to Zaire ebolavirus

Karen K. Wong, Richard T. Davey, Angela L. Hewlett, Colleen S. Kraft, Aneesh K. Mehta, Mark J. Mulligan, Allison Beck, William Dorman, Christopher J. Kratochvil, Lilin Lai, Tara N. Palmore, Susan Rogers, Philip W. Smith, Anthony F. Suffredini, Mark Wolcott, Ute Ströher, Timothy M. Uyeki

Research output: Contribution to journalArticlepeer-review

25 Scopus citations


From September 2014 to April 2015, 6 persons who had occupational exposures to Zaire ebolavirus in West Africa received investigational agent rVSV-ZEBOV or TKM-100802 for postexposure prophylaxis and were monitored in the United States. All patients experienced self-limited symptoms after postexposure prophylaxis; none developed Ebola virus disease.

Original languageEnglish (US)
Pages (from-to)376-379
Number of pages4
JournalClinical Infectious Diseases
Issue number3
StatePublished - Aug 1 2016


  • Ebola virus
  • TKM-Ebola
  • postexposure prophylaxis
  • vesicular stomatitis virus

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'Use of Postexposure Prophylaxis after Occupational Exposure to Zaire ebolavirus'. Together they form a unique fingerprint.

Cite this